CELYAD ONCOLOGY (CYAD.BR) Stock Income Statement
EBR:CYAD • BE0974260896
Current stock price
0.324 EUR
+0.01 (+3.18%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 21.00K | 186.00K | 102.00K | 0.00 | 0.00 | |||
| Cost Of Goods | 8.00K | 12.00K | 69.00K | 0.00 | 0.00 | |||
| Gross Profit | 13.00K | 174.00K | 33.00K | 0.00 | 0.00 | |||
| Operating Expenses | 1.45M | 6.04M | 9.58M | 5.77M | 26.39M | |||
| Research and Development | 3.28M | 2.89M | 3.88M | 17.70M | 19.50M | |||
| Selling, General, and Administrative Expenses | 3.74M | 3.10M | 5.96M | 10.34M | 9.66M | |||
| Operating Income | -1.44M | -5.87M | -9.54M | -5.77M | -26.39M | |||
| Interest Income/Expense | -43.00K | 72.00K | -41.00K | 2.00K | -206.00K | |||
| Other Income/Expense | -8.00K | -38.00K | -13.00K | -15.00K | 95.00K | |||
| Non Recurring Items | 2.32M | 12.00K | 1.09M | -35.08M | -1.00K | |||
| Income Before Taxes | 830.00K | -5.82M | -8.51M | -40.87M | -26.50M | |||
| Income Tax | N/A | 0.00 | -63.00K | 65.00K | 10.00K | |||
| Net Income | 830.00K | -5.82M | -8.45M | -40.94M | -26.51M | |||
| EBITDA | -1.27M | -5.42M | -8.75M | -4.33M | -24.87M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.02 | -0.14 | -0.33 | -1.81 | -1.70 | |||
| Statistics | ||||||||
| Gross Profit Margin | 61.90% | 93.55% | 32.35% | N/A | N/A | |||
| Profit Margin | 3952.38% | -3131.18% | -8282.35% | N/A | N/A | |||
| Operating Profit Margin | -6852.38% | -3155.91% | -9356.86% | N/A | N/A | |||
All data in EUR